Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPRC | P08575 | 3/20 | 0.47 |
| ▸ | PTPN13 | Q12923 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | TNF | P01375 | 1/20 | 0.43 |
| ▸ | PDE4A | P27815 | 1/20 | 0.43 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.43 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.43 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5350218 | 0.97 | PTPRC (0.48) | PTPRCPTPN13MEN1KMT2AHSD17B10 | |
| SCHEMBL5351912 | 0.94 | ALDH1A1 (0.47) | PTPRCPTPN13MEN1KMT2AHSD17B10 | |
| SCHEMBL28693655 | 0.92 | ALDH1A1 (0.47) | MEN1KMT2AHSD17B10ALDH1A1MAPT | |
| SCHEMBL30731584 | 0.90 | ALDH1A1 (0.47) | MEN1KMT2AHSD17B10ALDH1A1MAPT | |
| SCHEMBL23969638 | 0.90 | ALDH1A1 (0.47) | MEN1KMT2AHSD17B10ALDH1A1MAPT | |
| SCHEMBL3676598 | 0.88 | ASAH1 (0.48) | MEN1KMT2AHSD17B10ALDH1A1MAPT | |
| SCHEMBL3678799 | 0.86 | ASAH1 (0.50) | MEN1KMT2AHSD17B10ALDH1A1 | |
| SCHEMBL3678825 | 0.86 | ASAH1 (0.50) | MEN1KMT2AHSD17B10ALDH1A1 | |
| SCHEMBL3679722 | 0.86 | ASAH1 (0.50) | MEN1KMT2AHSD17B10ALDH1A1 | |
| SCHEMBL1537374 | 0.86 | ASAH1 (0.50) | MEN1KMT2AHSD17B10ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220024949-A1 | CU-AND NI-CATALYZED DECARBOXYLATIVE BORYLATION REACTIONS | THE SCRIPPS RESEARCH INSTITUTE | 2022-01-27 | — | — | US | disclosed |
| US-11161859-B2 | Cu- and Ni-catalyzed decarboxylative borylation reactions | THE SCRIPPS RESEARCH INSTITUTE (US) | 2021-11-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11161859-B2 | Cu- and Ni-catalyzed decarboxylative borylation reactions | PCSK9, LIPA, ACSL3 | PTPRC 3161/4885PTPN13 3614/4885MEN1 2765/4885 |
| US-20220024949-A1 | CU-AND NI-CATALYZED DECARBOXYLATIVE BORYLATION REACTIONS | PCSK9, PCSK7, PCSK6 | PTPRC 3434/4885PTPN13 3823/4885MEN1 2960/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.